Skip to main content

Ciglitazone

BML-GR205

8 citations

  • BML-GR205-0005   —   5 mg
    $150.00
  • BML-GR205-0025   —   25 mg
    $608.00

Ciglitazone is a thiazolidinedione type of antihyperglycemic agent. It displays antihyperglycemic activity in genetically obese C57 Bl/6 ob/ob mice and is a selective PPARγ agonist (EC50=3 µM). Inhibits HUVEC differentiation and angiogenesis and also stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only


Last modified: May 29, 2024